No attenuation of the ATM-dependent DNA damage response in murine telomerase-deficient cells

DNA Repair

Volumn 8, Issue 3, 2009, Pages 347-353

  Erdmann, Natalie ^a   Harrington, Lea A ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

ATM; DNA damage response; Murine; Telomerase reverse transcriptase; Telomeres

Indexed keywords

ATM PROTEIN; ETOPOSIDE; HISTONE H2AX; HISTONE H3; HISTONE H4; PROTEIN P53; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

ANIMAL CELL; ARTICLE; CELL CYCLE ARREST; CELL DEATH; CELL LINE; CHROMATIN; DNA DAMAGE; EMBRYONIC STEM CELL; ENZYME REPRESSION; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IRRADIATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; WESTERN BLOTTING; WILD TYPE;

ANIMALS; BLOTTING, WESTERN; CELL CYCLE PROTEINS; CELL LINE; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA DAMAGE; DNA-BINDING PROTEINS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HISTONES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN-SERINE-THREONINE KINASES; TELOMERASE; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

MAMMALIA; MURINAE;

EID: 59149086488     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dnarep.2008.11.009     Document Type: Article

References (85)

1. Masutomi K., Possemato R., Wong J.M., Currier J.L., Tothova Z., Manola J.B., Ganesan S., Lansdorp P.M., Collins K., and Hahn W.C. The telomerase reverse transcriptase regulates chromatin state and DNA damage responses. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 8222-8227
2. Price C., and Jacob N.K. Engineering the end: DNA processing at human telomeres. Mol. Cell 18 (2005) 147-148
3. Greider C.W. Telomeres and senescence: the history, the experiment, the future. Curr. Biol. 8 (1998) R178-R181
4. Hug N., and Lingner J. Telomere length homeostasis. Chromosoma 115 (2006) 413-425
5. Cohen S.B., Graham M.E., Lovrecz G.O., Bache N., Robinson P.J., and Reddel R.R. Protein composition of catalytically active human telomerase from immortal cells. Science 315 (2007) 1850-1853
6. Kelleher C., Teixeira M.T., Forstemann K., and Lingner J. Telomerase: biochemical considerations for enzyme and substrate. Trends Biochem. Sci. 27 (2002) 572-579
7. Bertuch A.A., and Lundblad V. The maintenance and masking of chromosome termini. Curr. Opin. Cell Biol. 18 (2006) 247-253
8. de Lange Shelterin T. the protein complex that shapes and safeguards human telomeres. Genes Dev. 19 (2005) 2100-2110
9. Gao H., Cervantes R.B., Mandell E.K., Otero J.H., and Lundblad V. RPA-like proteins mediate yeast telomere function. Nat. Struct. Mol. Biol. (2007)
10. Churikov D., Wei C., and Price C.M. Vertebrate POT1 restricts G-overhang length and prevents activation of a telomeric DNA damage checkpoint but is dispensable for overhang protection. Mol. Cell. Biol. 26 (2006) 6971-6982
11. Denchi E.L., and de Lange T. Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1. Nature 448 (2007) 1068-1071
12. Jacob N.K., Lescasse R., Linger B.R., and Price C.M. Tetrahymena POT1a regulates telomere length and prevents activation of a cell cycle checkpoint. Mol. Cell. Biol. 27 (2007) 1592-1601
13. Shakirov E.V., Surovtseva Y.V., Osbun N., and Shippen D.E. The Arabidopsis Pot1 and Pot2 proteins function in telomere length homeostasis and chromosome end protection. Mol. Cell. Biol. 25 (2005) 7725-7733
14. Surovtseva Y.V., Shakirov E.V., Vespa L., Osbun N., Song X., and Shippen D.E. Arabidopsis POT1 associates with the telomerase RNP and is required for telomere maintenance. EMBO J. 26 (2007) 3653-3661
15. Verdun R.E., Crabbe L., Haggblom C., and Karlseder J. Functional human telomeres are recognized as DNA damage in G2 of the cell cycle. Mol. Cell 20 (2005) 551-561
16. Frank C.J., Hyde M., and Greider C.W. Regulation of telomere elongation by the cyclin-dependent kinase CDK1. Mol. Cell 24 (2006) 423-432
17. Harrington L. Those dam-aged telomeres!. Curr. Opin. Genet. Dev. 14 (2004) 22-28
18. Herbig U., Jobling W.A., Chen B.P., Chen D.J., and Sedivy J.M. Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol. Cell 14 (2004) 501-513
19. von Zglinicki T., Saretzki G., Ladhoff J., d'Adda di Fagagna F., and Jackson S.P. Human cell senescence as a DNA damage response. Mech. Ageing Dev. 126 (2005) 111-117
20. d'Adda di Fagagna F., Teo S.H., and Jackson S.P. Functional links between telomeres and proteins of the DNA-damage response. Genes Dev. 18 (2004) 1781-1799
21. Reaper P.M., di Fagagna F., and Jackson S.P. Activation of the DNA damage response by telomere attrition: a passage to cellular senescence. Cell Cycle 3 (2004) 543-546
22. Chan S.W., and Blackburn E.H. New ways not to make ends meet: telomerase, DNA damage proteins and heterochromatin. Oncogene 21 (2002) 553-563
23. Hackett J.A., and Greider C.W. Balancing instability: dual roles for telomerase and telomere dysfunction in tumorigenesis. Oncogene 21 (2002) 619-626
24. Lydall D., and Whitehall S. Chromatin and the DNA damage response. DNA Repair (Amst) 4 (2005) 1195-1207
25. Shay J.W., and Wright W.E. Telomeres are double-strand DNA breaks hidden from DNA damage responses. Mol. Cell 14 (2004) 420-421
26. Wang R.C., Smogorzewska A., and de Lange T. Homologous recombination generates T-loop-sized deletions at human telomeres. Cell 119 (2004) 355-368
27. Capper R., Britt-Compton B., Tankimanova M., Rowson J., Letsolo B., Man S., Haughton M., and Baird D.M. The nature of telomere fusion and a definition of the critical telomere length in human cells. Genes Dev. 21 (2007) 2495-2508
28. Lustig A.J. Clues to catastrophic telomere loss in mammals from yeast telomere rapid deletion. Nat. Rev. Genet. 4 (2003) 916-923
29. Li B., and Lustig A.J. A novel mechanism for telomere size control in Saccharomyces cerevisiae. Genes Dev. 10 (1996) 1310-1326
30. Williams B., Bhattacharyya M.K., and Lustig A.J. Mre 11 p nuclease activity is dispensable for telomeric rapid deletion. DNA Repair (Amst) 4 (2005) 994-1005
31. Meier A., Fiegler H., Munoz P., Ellis P., Rigler D., Langford C., Blasco M.A., Carter N., and Jackson S.P. Spreading of mammalian DNA-damage response factors studied by ChIP-chip at damaged telomeres. EMBO J. 26 (2007) 2707-2718
32. d'Adda di Fagagna F., Reaper P.M., Clay-Farrace L., Fiegler H., Carr P., Von Zglinicki T., Saretzki G., Carter N.P., and Jackson S.P. A DNA damage checkpoint response in telomere-initiated senescence. Nature 426 (2003) 194-198
33. Silverman J., Takai H., Buonomo S.B., Eisenhaber F., and de Lange T. Human Rif1, ortholog of a yeast telomeric protein, is regulated by ATM and 53BP1 and functions in the S-phase checkpoint. Genes Dev. 18 (2004) 2108-2119
34. Takai H., Smogorzewska A., and de Lange T. DNA damage foci at dysfunctional telomeres. Curr. Biol. 13 (2003) 1549-1556
35. IJpma A.S., and Greider C.W. Short Telomeres Induce a DNA Damage Response in Saccharomyces cerevisiae. Mol. Biol. Cell 14 (2003) 987-1001
36. Hackett J., and Greider C.W. End resection initiates genomic instability in the absence of telomerase. Mol. Cell Biol. 23 (2003) 8450-8461
37. Hackett J.A., Feldser D.M., and Greider C.W. Telomere dysfunction increases mutation rate and genomic instability. Cell 106 (2001) 275-286
38. Myung K., Chen C., and Kolodner R.D. Multiple pathways cooperate in the suppression of genome instability in Saccharomyces cerevisiae. Nature 411 (2001) 1073-1076
39. Pennaneach V., Putnam C.D., and Kolodner R.D. Chromosome healing by de novo telomere addition in Saccharomyces cerevisiae. Mol. Microbiol. 59 (2006) 1357-1368
40. Feldser D.M., Hackett J.A., and Greider C.W. Telomere dysfunction and the initiation of genome instability. Nat. Rev. Cancer 3 (2003) 623-627
41. De Lange T. Telomere-related genome instability in cancer. Cold Spring Harb. Symp. Quant. Biol. 70 (2005) 197-204
42. Shay J., and Wright W.E. Does telomerase moonlight?. Scientist 18 (2005) 18-19
43. Lewis L.K., Karthikeyan G., Westmoreland J.W., and Resnick M.A. Differential suppression of DNA repair deficiencies of Yeast rad50, mre11 and xrs2 mutants by EXO1 and TLC1 (the RNA component of telomerase). Genetics 160 (2002) 49-62
44. Teo S.H., and Jackson S.P. Telomerase subunit overexpression suppresses telomere-specific checkpoint activation in the yeast yku80 mutant. EMBO Rep. 2 (2001) 197-202
45. Sarin K.Y., Cheung P., Gilison D., Lee E., Tennen R.I., Wang E., Artandi M.K., Oro A.E., and Artandi S.E. Conditional telomerase induction causes proliferation of hair follicle stem cells. Nature 436 (2005) 1048-1052
46. Flores I., Cayuela M.L., and Blasco M.A. Effects of telomerase and telomere length on epidermal stem cell behavior. Science 309 (2005) 1253-1256
47. Artandi S.E., Alson S., Tietze M.K., Sharpless N.E., Ye S., Greenberg R.A., Castrillon D.H., Horner J.W., Weiler S.R., Carrasco R.D., and DePinho R.A. Constitutive telomerase expression promotes mammary carcinomas in aging mice. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 8191-8196
48. Gonzalez-Suarez E., Geserick C., Flores J.M., and Blasco M.A. Antagonistic effects of telomerase on cancer and aging in K5-mTert transgenic mice. Oncogene 24 (2005) 2256-2270
49. Fu W., Killen M., Culmsee C., Dhar S., Pandita T.K., and Mattson M.P. The catalytic subunit of telomerase is expressed in developing brain neurons and serves a cell survival-promoting function. J. Mol. Neurosci. 14 (2000) 3-15
50. Lu C., Fu W., and Mattson M.P. Telomerase protects developing neurons against DNA damage-induced cell death. Brain Res. Dev. Brain Res. 131 (2001) 167-171
51. Kang H.J., Choi Y.S., Hong S.B., Kim K.W., Woo R.S., Won S.J., Kim E.J., Jeon H.K., Jo S.Y., Kim T.K., Bachoo R., Reynolds I.J., Gwag B.J., and Lee H.W. Ectopic expression of the catalytic subunit of telomerase protects against brain injury resulting from ischemia and NMDA-induced neurotoxicity. J. Neurosci. 24 (2004) 1280-1287
52. Lee J., Sung Y.H., Cheong C., Choi Y.S., Jeon H.K., Sun W., Hahn W.C., Ishikawa F., and Lee H.-W. TERT promotes cellular and organismal survival independently of telomerase activity. Oncogene 27 (2008) 3754-3760
53. Smith L.L., Coller H.A., and Roberts J.M. Telomerase modulates expression of growth-controlling genes and enhances cell proliferation. Nat. Cell Biol. 5 (2003) 474-479
54. Stewart S.A., Hahn W.C., O'Connor B.F., Banner E.N., Lundberg A.S., Modha P., Mizuno H., Brooks M.W., Fleming M., Zimonjic D.B., Popescu N.C., and Weinberg R.A. Telomerase contributes to tumorigenesis by a telomere length-independent mechanism. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 12606-12611
55. Cayuela M.L., Flores J.M., and Blasco M.A. The telomerase RNA component Terc is required for the tumour-promoting effects of Tert overexpression. EMBO Rep. 6 (2005) 268-274
56. Cheong C., Hong K.U., and Lee H.W. Mouse models for telomere and telomerase biology. Exp. Mol. Med. 35 (2003) 141-153
57. Greider C.W. Telomerase RNA levels limit the telomere length equilibrium. Cold Spring Harb. Symp. Quant. Biol. 71 (2006) 225-229
58. Harrington L. Making the most of a little: dosage effects in eukaryotic telomere length maintenance. Chromosome Res. 13 (2005) 493-504
59. Hathcock K.S., Hemann M.T., Opperman K.K., Strong M.A., Greider C.W., and Hodes R.J. Haploinsufficiency of mTR results in defects in telomere elongation. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 3591-3596
60. Hao L.Y., Armanios M., Strong M.A., Karim B., Feldser D.M., Huso D., and Greider C.W. Short telomeres, even in the presence of telomerase, limit tissue renewal capacity. Cell 123 (2005) 1121-1131
61. Erdmann N., Liu Y., and Harrington L. Distinct dosage requirements for the maintenance of long and short telomeres in mTert heterozygous mice. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 6080-6085
62. Yamaguchi H., Calado R.T., Ly H., Kajigaya S., Baerlocher G.M., Chanock S.J., Lansdorp P.M., and Young N.S. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. N. Engl. J. Med. 352 (2005) 1413-1424
63. Xin Z.T., Beauchamp A.D., Calado R.T., Bradford J.W., Regal J.A., Shenoy A., Liang Y., Lansdorp P.M., Young N.S., and Ly H. Functional characterization of natural telomerase mutations found in patients with hematologic disorders. Blood 109 (2007) 524-532
64. Goldman F., Bouarich R., Kulkarni S., Freeman S., Du H.Y., Harrington L., Mason P.J., Londono-Vallejo A., and Bessler M. The effect of TERC haploinsufficiency on the inheritance of telomere length. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 17119-17124
65. Armanios M., Chen J.L., Chang Y.P., Brodsky R.A., Hawkins A., Griffin C.A., Eshleman J.R., Cohen A.R., Chakravarti A., Hamosh A., and Greider C.W. Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 15960-15964
66. Vulliamy T., Marrone A., Goldman F., Dearlove A., Bessler M., Mason P.J., and Dokal I. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 413 (2001) 432-435
67. Vulliamy T.J., Knight S.W., Mason P.J., and Dokal I. Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita. Blood Cells Mol. Dis. 27 (2001) 353-357
68. Mitchell J.R., Wood E., and Collins K. A telomerase component is defective in the human disease dyskeratosis congenita. Nature 402 (1999) 551-555
69. Theimer C.A., Finger L.D., Trantirek L., and Feigon J. Mutations linked to dyskeratosis congenita cause changes in the structural equilibrium in telomerase RNA. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 449-454
70. Ly H., Schertzer M., Jastaniah W., Davis J., Yong S.L., Ouyang Q., Blackburn E.H., Parslow T.G., and Lansdorp P.M. Identification and functional characterization of 2 variant alleles of the telomerase RNA template gene (TERC) in a patient with dyskeratosis congenita. Blood 106 (2005) 1246-1252
71. Yamaguchi H., Baerlocher G.M., Lansdorp P.M., Chanock S.J., Nunez O., Sloand E., and Young N.S. Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome. Blood 102 (2003) 916-918
72. Goldkorn A., and Blackburn E.H. Assembly of mutant-template telomerase RNA into catalytically active telomerase ribonucleoprotein that can act on telomeres is required for apoptosis and cell cycle arrest in human cancer cells. Cancer Res. 66 (2006) 5763-5771
73. Li S., Rosenberg J.E., Donjacour A.A., Botchkina I.L., Hom Y.K., Cunha G.R., and Blackburn E.H. Rapid inhibition of cancer cell growth induced by lentiviral delivery and expression of mutant-template telomerase RNA and anti-telomerase short-interfering RNA. Cancer Res. 64 (2004) 4833-4840
74. Wong K.K., Chang S., Weiler S.R., Ganesan S., Chaudhuri J., Zhu C., Artandi S.E., Rudolph K.L., Gottlieb G.J., Chin L., Alt F.W., and DePinho R.A. Telomere dysfunction impairs DNA repair and enhances sensitivity to ionizing radiation. Nat. Genet. 26 (2000) 85-88
75. Liu Y., Kha H., Ungrin M., Robinson M.O., and Harrington L. Preferential maintenance of critically short telomeres in mammalian cells heterozygous for mTert. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 3597-3602
76. Liu Y., Snow B.E., Hande M.P., Yeung D., Erdmann N.J., Wakeham A., Itie A., Siderovski D.P., Lansdorp P.M., Robinson M.O., and Harrington L. The telomerase reverse transcriptase is limiting and necessary for telomerase function in vivo. Curr. Biol. 10 (2000) 1459-1462
77. Hao L.Y., Strong M.A., and Greider C.W. Phosphorylation of H2AX at short telomeres in T cells and fibroblasts. J. Biol. Chem. 279 (2004) 45148-45154
78. Smogorzewska A., and de Lange T. Different telomere damage signaling pathways in human and mouse cells. EMBO J. 21 (2002) 4338-4348
79. Aladjem M.I., Spike B.T., Rodewald L.W., Hope T.J., Klemm M., Jaenisch R., and Wahl G.M. ES cells do not activate p53-dependent stress responses and undergo p53-independent apoptosis in response to DNA damage. Curr. Biol. 8 (1998) 145-155
80. Hong Y., and Stambrook P.J. Restoration of an absent G1 arrest and protection from apoptosis in embryonic stem cells after ionizing radiation. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 14443-14448
81. Hirao A., Kong Y.Y., Matsuoka S., Wakeham A., Ruland J., Yoshida H., Liu D., Elledge S.J., and Mak T.W. DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 287 (2000) 1824-1827
82. Van Sloun P.P., Jansen J.G., Weeda G., Mullenders L.H., van Zeeland A.A., Lohman P.H., and Vrieling H. The role of nucleotide excision repair in protecting embryonic stem cells from genotoxic effects of UV-induced DNA damage. Nucleic Acids Res. 27 (1999) 3276-3282
83. Nagy A., Gertsenstein M., Vintersten K., and Behringer R. Manipulating the Mouse Embryo: A Laboratory Manual. third edition (2003), Cold Spring Harbor Laboratory Press, Cold Spring Harbor
84. Zijlmans J.M., Martens U.M., Poon S.S., Raap A.K., Tanke H.J., Ward R.K., and Lansdorp P.M. Telomeres in the mouse have large inter-chromosomal variations in the number of T2AG3 repeats. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 7423-7428
85. Blasco M.A., Lee H.W., Hande M.P., Samper E., Lansdorp P.M., DePinho R.A., and Greider C.W. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91 (1997) 25-34